Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study-Reference-Cited by-同舟云学术

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study

Published:2023-04-17 Issue:11 Volume:149 Page:8243-8253
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Bilici Ahmet^ORCID,Koca Sinan,Karaagac Mustafa,Aydin Sabin Goktas,Eraslan Emrah,Kaplan Muhammed Ali,Ocak Birol,Goksu Sema Sezgin,Paydas Semra,Akgul Fahri,Derin Sumeyye,Ergun Yakup,Yekeduz Emre,Erol Cihan,Ozyukseler Deniz Tataroglu,Demiray Atike Gokcen,Karaca Mustafa,Guc Zeynep Gulsum,Menekse Serkan,Cinkir Havva Yesil,Gumusay Ozge,Sakin Abdullah,Ozkul Ozlem,Demir Hacer,Erdem Dilek,Besiroglu Mehmet,Unal Olcun Umit,Acar Ramazan,Koral Lokman,Sahin Suleyman,Sakalar Teoman,Bahceci Aykut,Ozveren Ahmet,Gunaydin Ulug Mutlu,Seker Mehmet Metin,Sunar Veli,Dal Pinar,Artac Mehmet,Turhal Serdar

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-04766-3.pdf

Reference27 articles.

1. Alshamsan B, Badran A, Alshibany A et al (2021) Real-world outcome and prognostic factors of pazopanib in advanced soft tissue sarcoma. Cancer Manag Res 13:6755–6766. https://doi.org/10.2147/CMAR.S323499

2. Aykan MB, Keskin GS, Örnek E et al (2022) Efficacy of pazopanib in patients with pretreated advanced stage soft tissue sarcomas. Acta Oncologica Turcica 55:229–236. https://doi.org/10.5505/aot.2022.37108

3. Bajpai J, Mullapally SK, Kapoor A, Ghosh J, Rekhi B (2021) Pazopanib in metastatic soft tissue sarcomas: testing the waters in developing world. Indian J Cancer 58(3):365–370. https://doi.org/10.4103/ijc.IJC_314_19

4. Byar KL, Fredericks T (2022) Uterine leiomyosarcoma. J Adv Pract Oncol 13(1):70–76. https://doi.org/10.6004/jadpro.2022.13.1.6

5. Carroll C, Patel N, Gunsoy NB, Stirnadel-Farrant HA, Pokras S (2022) Meta-analysis of pazopanib and trabectedin effectiveness in previously treated metastatic synovial sarcoma (second-line setting and beyond). Future Oncol 18(32):3651–3665. https://doi.org/10.2217/fon-2022-0348